help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leveston, S. A.
Right arrow Articles by Daughaday, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leveston, S. A.
Right arrow Articles by Daughaday, W. H.

Journal of Clinical Endocrinology & Metabolism, Vol 53, 682-689, Copyright © 1981 by Endocrine Society

ARTICLES

Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor

SA Leveston, DW McKeel Jr, PJ Buckley, K Deschryver, MH Greider, BM Jaffe and WH Daughaday

We report an 18-yr-old youth with a metastatic foregut carcinoid tumor, Cushing's syndrome, and hypersomatotropic gigantism. Administration of cyproheptadine caused a dramatic fall in urinary cortisol excretion and plasma ACTH levels associated with clinical remission of the Cushing's syndrome. GH secretion was not affected by cyproheptadine administration. Ectopic ACTH secretion was confirmed by RIA of tumor extracts and immunohistochemical demonstration of ACTH-containing cells in hepatic metastases. There were two sources of GH production demonstrated in this patient. Ectopic secretion of GH by the carcinoid hepatic metastases was documented by both RIA and immunohistochemical techniques. A somatotrophic pituitary tumor was also present. The histological characteristics of this tumor suggest adenomatous hyperplasia rather than de novo neoplastic change as the likely mechanism of its pathogenesis. GH releasing factor-like activity was demonstrated in extracts of plasma and in extracts of the carcinoid tumor. We conclude that cyproheptadine exerted an effect on the ectopic ACTH-producing cells but not on the ectopic GH-producing cells or on adenohypophyseal GH secretion. Production of a GH releasing factor-like activity by the carcinoid tumor may have caused the pituitary somatotrophic tumor.


This article has been cited by other articles:


Home page
 NEJMHome page
F. Beuschlein, C. J. Strasburger, V. Siegerstetter, D. Moradpour, P. Lichter, M. Bidlingmaier, H. E. Blum, and M. Reincke
Acromegaly Caused by Secretion of Growth Hormone by a Non-Hodgkin's Lymphoma
N. Engl. J. Med., June 22, 2000; 342(25): 1871 - 1876.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Drange and S. Melmed
Long-Acting Lanreotide Induces Clinical and Biochemical Remission of Acromegaly Caused by Disseminated Growth Hormone-Releasing Hormone-Secreting Carcinoid
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3104 - 3109.
[Abstract] [Full Text]

Home page
 ScienceHome page
R Guillemin, P Brazeau, P Bohlen, F Esch, N Ling, and W. Wehrenberg
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly
Science, November 5, 1982; 218(4572): 585 - 587.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society